Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ?4 cm in size: an SEERMedicare analysis (English)
- New search for: Malhotra, J.
- New search for: Mhango, G.
- New search for: Gomez, J. E.
- New search for: Smith, C.
- New search for: Galsky, M. D.
- New search for: Strauss, G. M.
- New search for: Wisnivesky, J. P.
- New search for: Malhotra, J.
- New search for: Mhango, G.
- New search for: Gomez, J. E.
- New search for: Smith, C.
- New search for: Galsky, M. D.
- New search for: Strauss, G. M.
- New search for: Wisnivesky, J. P.
In:
ANNALS OF ONCOLOGY
;
26
, 4
;
768-773
;
2015
-
ISSN:
- Article (Journal) / Print
-
Title:Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ?4 cm in size: an SEERMedicare analysis
-
Contributors:Malhotra, J. ( author ) / Mhango, G. ( author ) / Gomez, J. E. ( author ) / Smith, C. ( author ) / Galsky, M. D. ( author ) / Strauss, G. M. ( author ) / Wisnivesky, J. P. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 26, 4 ; 768-773
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2015-01-01
-
Size:6 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 26, Issue 4
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 613
-
Different adjuvant chemotherapy regimens in older breast cancer patients?Wildiers, H. / Brain, E. et al. | 2015
- 615
-
Postoperative surveillance in nonmetastatic colorectal cancer patients: yes, butCastells, A. et al. | 2015
- 617
-
Adjuvant chemotherapy for rectal cancer after preoperative radiation or chemoradiation: One size does not fit allCervantes, A. / Glynne-Jones, R. et al. | 2015
- 620
-
Contralateral biopsies in patients with testicular germ-cell tumournuisance or new sense?Dieckmann, K. P. et al. | 2015
- 622
-
Neutrophil to lymphocyte ratio: another drop in the ocean of CRPC biomakers?Castro, E. / Lozano, R. / Olmos, D. et al. | 2015
- 624
-
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stageFindlay, J. M. / Middleton, M. R. / Tomlinson, I. et al. | 2015
- 644
-
Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysisPita-Fern�ndez, S. / Alhayek-A�, M. / Gonz�lez-Mart�n, C. / L�pez-Calvi�o, B. / Seoane-Pillado, T. / P�rtega-D�az, S. et al. | 2015
- 657
-
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomesGiannatempo, P. / Greco, T. / Mariani, L. / Nicolai, N. / Tana, S. / Far�, E. / Raggi, D. / Piva, L. / Catanzaro, M. / Biasoni, D. et al. | 2015
- 669
-
Designs of drug-combination phase I trials in oncology: a systematic review of the literatureRiviere, M. K. / Le Tourneau, C. / Paoletti, X. / Dubois, F. / Zohar, S. et al. | 2015
- 675
-
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialPerrone, F. / Nuzzo, F. / Di Rella, F. / Gravina, A. / Iodice, G. / Labonia, V. / Landi, G. / Pacilio, C. / Rossi, E. / De Laurentiis, M. et al. | 2015
- 682
-
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situCurigliano, G. / Disalvatore, D. / Esposito, A. / Pruneri, G. / Lazzeroni, M. / Guerrieri-Gonzaga, A. / Luini, A. / Orecchia, R. / Goldhirsch, A. / Rotmensz, N. et al. | 2015
- 688
-
Safety and efficacy outcomes with erythropoiesis-stimulating agents in patients with breast cancer: a meta-analysisAapro, M. / Moebus, V. / Nitz, U. / O'Shaughnessy, J. / Pronzato, P. / Untch, M. / Tomita, D. / Bohac, C. / Leyland-Jones, B. et al. | 2015
- 696
-
Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trialBreugom, A. J. / van Gijn, W. / Muller, E. W. / Berglund, . / van den Broek, C. B. / Fokstuen, T. / Gelderblom, H. / Kapiteijn, E. / Leer, J. W. / Marijnen, C. A. et al. | 2015
- 702
-
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trialGruenberger, T. / Bridgewater, J. / Chau, I. / Garc�a Alfonso, P. / Rivoire, M. / Mudan, S. / Lasserre, S. / Hermann, F. / Waterkamp, D. / Adam, R. et al. | 2015
- 709
-
Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)Koeberle, D. / Betticher, D. C. / von Moos, R. / Dietrich, D. / Brauchli, P. / Baertschi, D. / Matter, K. / Winterhalder, R. / Borner, M. / Anchisi, S. et al. | 2015
- 715
-
Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trialsHaller, D. G. / O'Connell, M. J. / Cartwright, T. H. / Twelves, C. J. / McKenna, E. F. / Sun, W. / Saif, M. W. / Lee, S. / Yothers, G. / Schmoll, H. J. et al. | 2015
- 724
-
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trialMasi, G. / Salvatore, L. / Boni, L. / Loupakis, F. / Cremolini, C. / Fornaro, L. / Schirripa, M. / Cupini, S. / Barbara, C. / Safina, V. et al. | 2015
- 731
-
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatmentMorelli, M. P. / Overman, M. J. / Dasari, A. / Kazmi, S. M. / Mazard, T. / Vilar, E. / Morris, V. K. / Lee, M. S. / Herron, D. / Eng, C. et al. | 2015
- 737
-
Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based studyKier, M. G. / Lauritsen, J. / Almstrup, K. / Mortensen, M. S. / Toft, B. G. / Rajpert-De Meyts, E. / Skakkebaek, N. E. / R�rth, M. / von der Maase, H. / Agerbaek, M. et al. | 2015
- 743
-
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trialsvan Soest, R. J. / Templeton, A. J. / Vera-Badillo, F. E. / Mercier, F. / Sonpavde, G. / Amir, E. / Tombal, B. / Rosenthal, M. / Eisenberger, M. A. / Tannock, I. F. et al. | 2015
- 750
-
Baseline neutrophillymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid useLorente, D. / Mateo, J. / Templeton, A. J. / Zafeiriou, Z. / Bianchini, D. / Ferraldeschi, R. / Bahl, A. / Shen, L. / Su, Z. / Sartor, O. et al. | 2015
- 756
-
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomesKote-Jarai, Z. / Mikropoulos, C. / Leongamornlert, D. A. / Dadaev, T. / Tymrakiewicz, M. / Saunders, E. J. / Jones, M. / Jugurnauth-Little, S. / Govindasami, K. / Guy, M. et al. | 2015
- 762
-
A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancerLim, S. H. / Lee, J. Y. / Lee, M. Y. / Kim, H. S. / Lee, J. / Sun, J. M. / Ahn, J. S. / Um, S. W. / Kim, H. / Kim, B. S. et al. | 2015
- 768
-
Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ?4 cm in size: an SEERMedicare analysisMalhotra, J. / Mhango, G. / Gomez, J. E. / Smith, C. / Galsky, M. D. / Strauss, G. M. / Wisnivesky, J. P. et al. | 2015
- 774
-
Utility of 18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphomaHorwitz, S. / Coiffier, B. / Foss, F. / Prince, H. M. / Sokol, L. / Greenwood, M. / Caballero, D. / Morschhauser, F. / Pinter-Brown, L. / Iyer, S. P. et al. | 2015
- 779
-
European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?Malvezzi, M. / Bertuccio, P. / Rosso, T. / Rota, M. / Levi, F. / La Vecchia, C. / Negri, E. et al. | 2015
- 787
-
Low-dose aspirin use and the risk of ovarian cancer in DenmarkBaandrup, L. / Kjaer, S. K. / Olsen, J. H. / Dehlendorff, C. / Friis, S. et al. | 2015
- 793
-
Expression of estrogen receptors in non-malignant mammary tissue modifies the association between insulin-like growth factor 1 and breast cancer riskSamoli, E. / Lagiou, A. / Zourna, P. / Barbouni, A. / Georgila, C. / Tsikkinis, A. / Vassilarou, D. / Minaki, P. / Sfikas, C. / Spanos, E. et al. | 2015
- 798
-
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II studyDi Giacomo, A. M. / Ascierto, P. A. / Queirolo, P. / Pilla, L. / Ridolfi, R. / Santinami, M. / Testori, A. / Simeone, E. / Guidoboni, M. / Maurichi, A. et al. | 2015
- 804
-
Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancerBendell, J. / O'Reilly, E. M. / Middleton, M. R. / Chau, I. / Hochster, H. / Fielding, A. / Burke, W. / Burris, H. et al. | 2015
- 812
-
Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinomaBellmunt, J. / Mullane, S. A. / Werner, L. / Fay, A. P. / Callea, M. / Leow, J. J. / Taplin, M. E. / Choueiri, T. K. / Hodi, F. S. / Freeman, G. J. et al. | 2015
- 818
-
Surrogate end points for overall survival. Festina lente (more haste, less speed)Braillon, A. et al. | 2015
- 818
-
Reply to the letter to the editor Surrogate end points for overall survival. Festina lente (more haste, less speed) by BraillonMaeda, H. / Kurokawa, T. et al. | 2015
- 819
-
Atypical femur fractures associated with use of bisphosphonates and denosumabFarooki, A. / Fornier, M. / Boland, P. et al. | 2015
- 820
-
Reply to the letter to the editor Albumin to globulin ratio, a predictor or a misleader? by Alkan et al.Suh, B. / Park, S. / Shin, D. W. et al. | 2015
- 821
-
Obesity and cancer: links with survival differ from those with incidenceRenehan, A. G. et al. | 2015
- 822
-
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset| 2015